← Leaderboards
Karl B Thor
Duke University
$7,657,909
Attributed
$7,657,909
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,657,909 · 8
By mechanism
R44$5,495,559 · 3
R43$967,191 · 3
R01$925,788 · 1
R41$269,371 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Steven R Vigna$1,269,819
- Soman N Abraham$19,189,659
- Herman F. Staats$31,192,841
- Jaimie D Nathan$79,512
- Madan M Kwatra$4,025,703
Others in their field
Top investigators on “Incontinence”
- Marie G Gantz · Research Triangle Institute$31,085,807
- Sharon L Tennstedt · New England Research Institutes, Inc.$16,847,458
- Holly E Richter · University Of Alabama At Birmingham$12,355,664
- Linda J Waite · University Of Chicago$12,029,335
- Alison Huang · University Of California, San Francisco$11,757,160
- Tom F Lue · University Of California San Francisco$10,209,526
Research focus
IncontinenceCatheterizationPharmaceutical PreparationsBladderUrinationUrinary Tract InfectionCanis FamiliarisMiniature SwineIntestinesUrinary IncontinenceAwakeSpinal Cord InjuryUrineFecesPre-ClinicalMediatingFecal IncontinenceRattusSmall Business Innovation Research GrantFrequenciesFunctional DisorderContractsAnimalsDose
Grant awards (16)
Therapy for Fecal Incontinence and FecalUrgency$391,458
R43 · FY2024 · DK · contact PI
Pudendal neuromodulation for urinary and fecal incontinence and sphincter dyssynergia$50,000
R44 · FY2022 · NS · contact PI
Pudendal neuromodulation for urinary and fecal incontinence and sphincter dyssynergia$431,363
R44 · FY2021 · NS · contact PI
Pudendal neuromodulation for urinary and fecal incontinence and sphincter dyssynergia$941,206
R44 · FY2020 · NS · contact PI
Development of a first-in-class therapeutic for producing 'on-demand' voiding$998,525
R44 · FY2019 · DK · contact PI
Pudendal neuromodulation for incontinence and sphincter dyssynergia after spinal injury$269,371
R41 · FY2019 · NS · contact PI
Development of a first-in-class therapeutic for producing 'on-demand' voiding$1,001,467
R44 · FY2018 · DK · contact PI
An optimized NK2R agonist for 'on-demand' voiding$614,817
R44 · FY2018 · AG · contact PI
An optimized NK2R agonist for 'on-demand' voiding$1,158,181
R44 · FY2017 · AG · contact PI
Development of a first-in-class therapeutic for producing 'on-demand' voiding$300,000
R44 · FY2017 · DK · contact PI
A neurokinin receptor agonist to treat underactive bladder in the elderly$299,989
R43 · FY2017 · AG · contact PI
Identification of an optimized NK2R agonist for 'on-demand' voiding$275,744
R43 · FY2016 · AG · contact PI
PARTURITION INDUCED PELVIC FLOOR NEUROPATHY$231,427
R01 · FY2003 · HD
PARTURITION INDUCED PELVIC FLOOR NEUROPATHY$227,262
R01 · FY2002 · HD
PARTURITION INDUCED PELVIC FLOOR NEUROPATHY$251,229
R01 · FY2001 · HD
PARTURITION INDUCED PELVIC FLOOR NEUROPATHY$215,870
R01 · FY2000 · HD